 

Active ingredient: Aminosalicylic Acid 

 

Form/Route: Delayed Release Granules/Oral 

 

Recommended studies: 3 studies 

 

1. Type of study: Fasting 
Design: Single-dose, two-way, crossover in-vivo 

Strength: 4 gm 

Subjects: Normal healthy males and females, general population 

Additional Comments: Females should not be pregnant or lactating, and if applicable, 
should practice abstention or contraception during the study. The test and reference 
products should be administered by suspending the granules in orange or tomato juice. 

The pH of the food in which the granules are suspended should be less than 5. Care 
should be taken during the administration of these granules to protect the acid-resistant 
coating by maintaining the granules in an acidic environment during administration. The 
product should be stored in a refrigerator or freezer, but may be stored at room 
temperature for short periods of time. Avoid exposure of the drug to moisture, heat or 
light. 




______________________________________________________________________________ 

 

2. Type of study: Fed 
Design: Single-dose, two-way, crossover in-vivo 

Strength: 4 gm 

Subjects: Normal healthy males and females, general population 

Additional comments: Please see comments above. 




_____________________________________________________________________________ 

 

3. Type of study: Fasting sprinkle-in-applesauce 
Design: Single-dose, two-way, crossover in-vivo 

Strength: 4 gm 

Subjects: Normal healthy males and females, general population 

Additional comments: Please administer the dose after sprinkling the entire contents of 
the capsule on a teaspoonful of applesauce in accordance with the approved labeling of 
the RLD. Please see comments above. 




_____________________________________________________________________________ 

 

Analytes to measure: Aminosalicylic acid in serum 

 

Bioequivalence based on (90% CI): Aminosalicylic acid 


 

Waiver request of in-vivo testing: Not Applicable 

 

Dissolution test method and sampling times: 

 

Please note that a Dissolution Methods Database is available to the public at the OGD website 
at http://www.fda.gov/cder/ogd/index.htm. Please find the dissolution information for this 
product at this website. Please conduct comparative dissolution testing on 12 dosage units each 
of all strengths of the test and reference products. Specifications will be determined upon review 
of the application. 

 


